Olin stock hits 52-week low at 16.35 USD

“As demand for infrastructure and public-sector financing continues to grow, we are focused on delivering the same differentiated expertise and client-first approach that has defined our firm since its founding in 2009,” Academy Securities CEO Chance Mims said.Academy Securities Academy Securities has expanded aggressively since hiring head of municipal banking Frank Oh in June.  Processing…

Mariner, the Overland Park, Kan.-based national registered investment advisor that manages more than $630 billion in client assets, has entered a five-year partnership with technology provider Humanity Labs to scale an artificial intelligence workforce representing more than 700 full-time equivalents across its operations. Humanity Labs founder and CEO Andrei Pop describes his company and its…

A survey of lettings professionals has identified five core areas where human expertise remains essential, despite the growing adoption of artificial intelligence in the property sector. Research conducted by Propoly found that letting agents consider relationship building with landlords, handling difficult conversations or disputes, dealing with sensitive tenant circumstances, assessing situations with no clear-cut answer,…

Processing Content Key insight: A long-time Illinois banker has been banned from the industry for approving mortgages based on faulty appraisals. Expert quote: Burns “ignored inconsistencies and irregularities in the appraisals that should have called into question their accuracy.” —Federal Reserve enforcement action. Forward look: The prohibition order against Burns is indefinite and can only…

UMortgage’s team of 246 loan officers originated approximately $2.05 billion over the past 12 months. The addition brings NEXA’s combined loan officer count to more than 4,000 and pushes its annual origination volume to approximately $14.15 billion. In 2025 alone, UMortgage funded $2.57 billion across 6,678 loans, according to previously reported company figures. A model…

Good news for shareholders in the International Biotechnology Trust: their fund has a significant holding in US cancer research business Nuvalent, for which GSK has just agreed to pay $10.6 billion– 40% more than its share price prior to the deal being announced. Even better: Nuvalent is the sixth company in the portfolio to have…